By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clarus Therapeutics 

500 Skokie Boulevard
Suite 250
Northbrook  Illinois    U.S.A.
Phone: 847-562-4300 Fax: 847-562-4306


Company News
Clarus Therapeutics Re-Submits JATENZO NDA Following Positive Results Of inTUne Trial 6/26/2017 8:47:12 AM
Clarus Therapeutics Provides Update On Patent Infringement Lawsuit Against Lipocine (LPCN)'s Oral Product For Testosterone Replacement Therapy 10/13/2016 8:15:26 AM
Clarus Therapeutics Seeks Injunction Against The Marketing Of Lipocine Inc. (LPCN)'s Oral Product For Testosterone Replacement Therapy (LPCN 1021) 11/3/2015 7:42:50 AM
FDA Panel Denies Clarus Therapeutics' Oral Testosterone Drug Rextoro 9/18/2014 4:15:54 PM
Clarus Therapeutics Expands Board of Directors With Appointment Of Two Pharmaceutical Industry Veterans 7/22/2014 2:47:09 PM
Clarus Therapeutics Presents Phase 3 Data For REXTORO® For Men With Hypogonadism 6/23/2014 7:45:16 AM
Clarus Therapeutics Locks In $31.5 Million 6/12/2014 7:13:19 AM
Clarus Therapeutics To Present Phase 3 Data For REXTORO® At ICE/ENDO 2014 5/28/2014 9:14:18 AM
Testosterone Biotech Clarus Therapeutics Files For A $86 Million IPO 5/27/2014 8:27:40 AM
Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer 5/21/2014 9:22:52 AM